Evidence map›Paper›PMID 17338180›Full record

ReviewAdvances in experimental medicine and biology2007

DNA replication to aid somatic hypermutation.

Zhenming Xu, Hong Zan, Zsuzsanna Pal, Paolo Casali

Abstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenming XuCenter for Immunology, School of Medicine, University of California, Irvine, CA 92697-4120, USA.
Hong Zan
Zsuzsanna Pal
Paolo Casali

Funding

Somatic hypermutation and class switching in autoimmunityR01AI079705 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2010 to 2019
$4.1M
Immunoglobulin class switch DNA recombinationR01AI045011 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 2000 to 2011
$3.8M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
SOMATIC HYPERMUTATION IN HUMAN B CELLSR01AR040908 · NIAMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CASALI, PAOLO · 1992 to 2005
$1.8M
Immunoglobulin class switch DNA recombinationR56AI045011 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2012 to 2012
$523k
NIAID NIH HHS AI 45011NIAID NIH HHS AI 60573NIAID NIH HHS R01 AI045011NIAID NIH HHS R01 AI079705NIAID NIH HHS R56 AI045011NIAID NIH HHS T32 AI060573NIAMS NIH HHS AR 40908NIAMS NIH HHS R01 AR040908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA ReplicationMutationAnimalsHumansProliferating Cell Nuclear AntigenRNA-Binding Protein FUSProliferating Cell Nuclear AntigenRNA-Binding Protein FUS

Identifiers

PMID17338180
PMCPMC3140876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.